Skip to main content

Ardelyx, Inc.

ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001437402

In the last 90 days, Ardelyx, Inc. insiders filed 0 open-market purchases and 9 sales; 250 institutions reported holding it in 13F filings for Q2 2026, worth $906.4M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Ardelyx, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
9 filings
8 insiders, $697.1K in total
Insiders trading
8
Net value
−$697.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Ardelyx, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Ardelyx, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Hohenleitner SusanChief Financial Officer227,520Aug 25, 20264
Reilly Joseph JamesSee Remarks145,854Aug 25, 20265
Bishop John ESee Remarks317,095Aug 25, 20264
Brady James ParkerChief Human Resources Officer245,930Aug 25, 20264
Foster Eric DuaneChief Commercial Officer409,410Aug 25, 20265
Kelliher MikeChief Business Officer349,660Aug 25, 20265
Williams Laura AChief Patient Officer367,456Aug 25, 20267
Raab MichaelPresident & CEO1,619,792Aug 25, 202611
Mott David MDirector3,349,655Jun 18, 20262
Bertrand William C JRDirector329,507Jun 18, 20261
Rodgers Richard JDirector439,998Jun 18, 20261
Bazemore Robert BDirector68,006Jun 18, 20261
Parsey MerdadDirector83,746Jun 18, 20261
Cadoret-Manier OnaizaDirector178,156Jun 18, 20261
Bhanji MunaDirector163,808Jun 18, 20261
Grammer Elizabeth ASee Remarks299,895Nov 25, 20251
Renz Justin AChief Financial Officer409,052Aug 25, 20250
Rosenbaum David P.Chief Development Officer151,373IndirectNov 22, 20240
Blanks RobertSee Remarks314,421Nov 22, 20240
Felsch Robert OraSee Remarks91,560Aug 22, 20240
Rodriguez SusanChief Commercial Officer449,092May 23, 20240
Lundberg Jan MDirector146,794Jun 16, 20230
Block Geoffrey A.Director–Jun 16, 20230
Sandell Scott D10% Owner2,258,850IndirectDec 27, 20210
Baskett Forest10% Owner2,258,850IndirectDec 27, 20210
Jacobs Jeffrey WChief Scientific Officer119,483Nov 24, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 17, 2024 (view filing)Jul 152 daysRaab MichaelPresident & CEOSSale−7.50K$5.97−$44.8K−0.6%1.26M after10b5-1
Jun 28, 2024 (view filing)Jun 28Same dayRaab MichaelPresident & CEOSSale−2.31K$6.59−$15.2K−0.2%1.27M after10b5-1
Jun 25, 2024 (view filing)Jun 214 daysBlanks RobertSee RemarksSSale−38.0K$5.96−$226.5K−10.5%324.3K after10b5-1
Jun 17, 2024 (view filing)Jun 134 daysRaab MichaelPresident & CEOSSale−35.0K$6.65−$232.8K−2.7%1.27M after10b5-1
Jun 7, 2024 (view filing)Jun 52 daysWilliams Laura AChief Medical OfficerSSale−145.0K$7.13−$1.03M−31.0%322.2K after2 lots
Jun 5, 2024 (view filing)Jun 32 daysRosenbaum David P.Chief Development OfficerSSale−17.9K$7.00−$125.1K−10.1%158.5K after
May 31, 2024 (view filing)May 292 daysRaab MichaelPresident & CEOSSale−7.50K$6.72−$50.4K−0.6%1.27M after10b5-1
May 23, 2024 (view filing)May 212 daysWilliams Laura AChief Medical OfficerSSale−4.79K$7.81−$37.4K−1.3%367.2K after
May 23, 2024 (view filing)May 212 daysRosenbaum David P.Chief Development OfficerSSale−4.86K$7.81−$37.9K−1.3%376.5K after
May 23, 2024 (view filing)May 212 daysRosenbaum David P.Chief Development OfficerSSale−2.20K$7.81−$17.2K−1.2%176.4K after
May 23, 2024 (view filing)May 212 daysRodriguez SusanChief Commercial OfficerSSale−6.70K$7.81−$52.4K−1.5%449.1K after
May 23, 2024 (view filing)May 212 daysRenz Justin AChief Financial OfficerSSale−5.17K$7.81−$40.4K−1.7%300.5K after
May 23, 2024 (view filing)May 212 daysRaab MichaelPresident & CEOSSale−31.5K$7.81−$245.9K−2.4%1.28M after
May 23, 2024 (view filing)May 212 daysGrammer Elizabeth ASee RemarksSSale−6.93K$7.81−$54.1K−3.4%199.5K after
May 23, 2024 (view filing)May 212 daysFelsch Robert OraSee RemarksSSale−3.48K$7.81−$27.2K−3.5%95.1K after
May 23, 2024 (view filing)May 212 daysBlanks RobertSee RemarksSSale−4.86K$7.81−$37.9K−1.3%362.3K after
May 15, 2024 (view filing)May 141 dayRaab MichaelPresident & CEOSSale−3.00K$7.99−$24.0K−0.2%1.31M after10b5-1
May 9, 2024 (view filing)May 63 daysLateFelsch Robert OraSee RemarksSSale−208.0K$8.81−$1.83M−68.4%95.9K after2 lots
May 9, 2024 (view filing)May 63 daysLateGrammer Elizabeth ASee RemarksSSale−284.2K$8.88−$2.52M−58.2%203.8K after2 lots
May 7, 2024 (view filing)May 34 daysGrammer Elizabeth ASee RemarksSSale−45.0K$9.00−$405.0K−14.4%268.0K after10b5-1
May 7, 2024 (view filing)May 34 daysWilliams Laura AChief Medical OfficerSSale−39.9K$8.35−$333.6K−9.7%370.2K after10b5-1
May 1, 2024 (view filing)Apr 292 daysRaab MichaelPresident & CEOSSale−30.0K$6.40−$192.0K−2.2%1.31M after10b5-1
Apr 17, 2024 (view filing)Apr 152 daysRaab MichaelPresident & CEOSSale−7.50K$7.06−$53.0K−0.6%1.31M after10b5-1
Apr 2, 2024 (view filing)Apr 11 dayRaab MichaelPresident & CEOSSale−1.52K$7.31−$11.1K−0.1%1.32M after10b5-1
Mar 22, 2024 (view filing)Mar 202 daysGrammer Elizabeth ASee RemarksSSale−86.0K$7.73−$664.8K−21.6%313.0K after10b5-1
Feb 28, 2024 (view filing)Feb 262 daysRosenbaum David P.Chief Development OfficerSSale−5.18K$9.20−$47.7K−2.9%175.9K after
Feb 22, 2024 (view filing)Feb 202 daysRosenbaum David P.Chief Development OfficerSSale−5.02K$8.75−$43.9K−1.3%379.0K after
Feb 22, 2024 (view filing)Feb 202 daysRosenbaum David P.Chief Development OfficerSSale−2.29K$8.75−$20.1K−1.3%181.1K after
Feb 22, 2024 (view filing)Feb 202 daysRenz Justin AChief Financial OfficerSSale−5.34K$8.75−$46.7K−1.7%304.8K after
Feb 22, 2024 (view filing)Feb 202 daysRaab MichaelPresident & CEOSSale−22.9K$8.75−$200.5K−1.7%1.32M after
Feb 22, 2024 (view filing)Feb 202 daysBlanks RobertSee RemarksSSale−5.02K$8.75−$43.9K−1.3%368.2K after
Feb 22, 2024 (view filing)Feb 202 daysGrammer Elizabeth ASee RemarksSSale−4.43K$8.75−$38.8K−1.1%399.0K after
Feb 22, 2024 (view filing)Feb 202 daysRodriguez SusanChief Commercial OfficerSSale−6.93K$8.75−$60.6K−1.5%452.8K after
Feb 22, 2024 (view filing)Feb 202 daysFelsch Robert OraSee RemarksSSale−2.35K$8.75−$20.6K−1.3%184.8K after
Feb 22, 2024 (view filing)Feb 202 daysWilliams Laura AChief Medical OfficerSSale−4.80K$8.75−$42.0K−1.2%380.1K after
Feb 9, 2024 (view filing)Feb 81 dayRosenbaum David P.Chief Development OfficerSSale−15.3K$9.18−$140.9K−3.8%384.0K after10b5-1
Jan 10, 2024 (view filing)Jan 82 daysRosenbaum David P.Chief Development OfficerSSale−30.0K$6.64−$199.2K−9.5%286.6K after10b5-1
Dec 28, 2023 (view filing)Dec 262 daysRenz Justin AChief Financial OfficerSSale−225.0K$6.36−$1.43M−55.2%182.4K after10b5-1
Dec 20, 2023 (view filing)Dec 182 daysRosenbaum David P.Chief Development OfficerSSale−5.67K$6.07−$34.4K−1.8%316.6K after10b5-1
Dec 15, 2023 (view filing)Dec 141 dayRosenbaum David P.Chief Development OfficerSSale−7.00K$5.55−$38.9K−2.1%322.3K after10b5-1
Dec 13, 2023 (view filing)Dec 112 daysGrammer Elizabeth ASee RemarksSSale−50.0K$5.08−$254.0K−15.4%275.7K after10b5-1
Dec 8, 2023 (view filing)Dec 8Same dayRosenbaum David P.Chief Development OfficerSSale−20.0K$5.27−$105.4K−5.7%329.3K after10b5-1
Dec 6, 2023 (view filing)Dec 51 dayRosenbaum David P.Chief Development OfficerSSale−10.3K$5.00−$51.4K−2.9%349.3K after10b5-1
Dec 1, 2023 (view filing)Nov 301 dayRosenbaum David P.Chief Development OfficerSSale−3.00K$4.50−$13.5K−0.8%359.5K after10b5-1
Nov 22, 2023 (view filing)Nov 202 daysWilliams Laura AChief Medical OfficerSSale−2.58K$4.36−$11.3K−1.0%266.2K after
Nov 22, 2023 (view filing)Nov 202 daysRosenbaum David P.Chief Development OfficerSSale−2.83K$4.36−$12.4K−0.8%362.5K after
Nov 22, 2023 (view filing)Nov 202 daysRosenbaum David P.Chief Development OfficerSSale−932$4.36−$4.06K−0.8%113.3K after
Nov 22, 2023 (view filing)Nov 202 daysRodriguez SusanChief Commercial OfficerSSale−4.71K$4.36−$20.6K−1.3%347.0K after
Nov 22, 2023 (view filing)Nov 202 daysRenz Justin AChief Financial OfficerSSale−2.87K$4.36−$12.5K−0.9%332.4K after
Nov 22, 2023 (view filing)Nov 202 daysRaab MichaelPresident & CEOSSale−11.4K$4.36−$49.6K−1.3%867.9K after